Home

The Latest Stories

Sleep woes common in US, Canadian cops

About 40 percent of police officers in the United States and Canada suffer from sleep problems that may harm their ability to function on the job, said a US study published on Tuesday.

Of nearly 5,000 police officers who took part in an online survey, 40 percent had at least one sleep disorder, most commonly obstructive sleep apnea, followed ...

Sleep disorders common among cops: study

(Reuters Health) - A survey from the United States and Canada found 40 percent of police officers had symptoms of a sleep disorder, including sleep apnea and insomnia.

Officers who screened positive for those disorders were also more likely to be burned out, depressed or have an anxiety disorder. Over the next two years, they committed more administrative errors and safety ...

Sleep disorders common in cops: study

NEW YORK (Reuters Health) - A survey from the United States and Canada found 40 percent of police officers had symptoms of a sleep disorder, including sleep apnea and insomnia.

Officers who screened positive for those disorders were also more likely to be burnt out, depressed or have an anxiety disorder. And over the next two years, they committed more administrative ...

Pfizer's Lyrica helps in restless legs syndrome study

(Reuters) - Pfizer Inc's Lyrica pain treatment benefited patients with Restless Legs Syndrome in a late-stage clinical study, the company said on Friday.

The Phase III study of more than 700 patients met its three main goals, Pfizer said.

Restless Legs Syndrome is an urge to move the legs, and sometimes other parts of the body, particularly at night, preventing ...

The US Food and Drug Administration, for the first time, approved Wednesday medication specifically designed for those who wake up in the middle of the night and cannot fall back to sleep.

Intermezzo, manufactured by Transcept Pharmaceuticals of California, is a lower-dose formulation of zolpidem, first approved in the United States in 1992 and better known as the insomnia treatment ...

Transcept finally gets FDA nod on Intermezzo

(Reuters) - Transcept Pharmaceuticals Inc said the U.S. health regulator has approved its sleep drug Intermezzo as a first-of-its kind treatment of a particular type of insomnia.

The approval -- after two rejections earlier -- comes four days before the review date originally assigned by the U.S. Food and Drug Administration for the drug.

Intermezzo, chemically known as zolpidem tartrate sublingual ...

No extra restless legs syndrome in Parkinson's

NEW YORK (Reuters Health) - Contrary to previous findings, a new study hints that restless legs syndrome, or RLS, is not more common in people with early Parkinson's disease.

Because the night-time involuntary jerking and flexing is sometimes treated with the same type of drugs as Parkinson's, researchers have wondered if they're related, as some reports have suggested ...

Insomnia tied to depression risk in Japan

NEW YORK (Reuters Health) - People who struggle to get a good night's sleep are twice as likely, on average, to suffer from depression down the road as those who sleep soundly, Japanese researchers report.

After surveying thousands of adults in a rural Japanese town over the course of two years, a team from Tokyo Medical University found that participants ...

Michael Jackson begged to be given a propofol drip to help him sleep two months before he died, saying medics had assured him it was safe, a nurse told his doctor's manslaughter trial Tuesday.

The King of Pop told nurse Cherilyn Lee, a holistic expert, that doctors had told him he could take the drug -- a surgical anesthetic -- intravenously ...

Insomnia linked to higher heart attack risk

As if you didn't have enough to worry about during those sleepless nights, a Norwegian study out Monday suggests that people with insomnia face a 27 to 45 percent higher risk of heart attack.

About one-third of people report having trouble sleeping and should see a doctor for help, urged the authors of the study published in Circulation, a ...

Previous